News Cancer biotech BeyondSpring hit by weak IPO Hoping for $100m, biotech raises under $3.5 million on stock market
News Brexit could deny children access to cancer drug trials Experts call for shake-up of EU regulation.
News Kite and Fosun appoint leader for CAR-T debut in China But rival Juno finally gives up on lead therapy.
News Google AI detects breast cancer better than pathologists Algorithm achieves a sensitivity rate of 92%.
News Blow for MSD as NICE rejects Keytruda in first line lung can... Firm will have to offer further discount to get drug to NHS patients.
Views & Analysis Orphan drugs will fuel pharma's future - and a pricing pushb... Evaluate predicts sales could approach $8bn if approved.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
